United States - English - NLM (National Library of Medicine)

solutech pharmaceuticals llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 0.1 mg in 1 ml - do not use if known hypersensitivity to any of the listed ingredients of any of the components included in the kit. fluocinolone acetonide topical solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of components of the preparation. contraindicated in patients with known hypersensitivity to any of the listed ingredients. for alleviating tension on the scar and its surrounding skin. tension on a wound and scar is known to increase scar tissue formation. because of its adherence, silicone tape reduces tension (e.g. tear and stretch) along the incision line or wound which is known to minimize the degree of scarring in terms of spreading or thickening.

United States - English - NLM (National Library of Medicine)

solutech pharmaceuticals llc - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 0.1 mg in 1 ml - do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit. fluocinolone acetonide topical solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of components of the preparation. keratolytic for alleviating tension on the scar and its surrounding skin. tension on a wound and scar is known to increase scar tissue formation. because of its adherence, silicone tape reduces tension (e.g. tear and stretch) along the incision line or wound which is known to minimize the degree of scarring in terms of spreading or thickening.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reig jofre uk ltd - neomycin sulfate; fluocinolone acetonide - cutaneous cream - 5mg/1gram ; 250microgram/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reig jofre uk ltd - neomycin sulfate; fluocinolone acetonide - cutaneous ointment - 5mg/1gram ; 250microgram/1gram

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - neo-synalar® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see warnings section) . topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product should not be used in the external auditory canal if the eardrum is perforated.

United States - English - NLM (National Library of Medicine)

medimetriks pharmaceuticals - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - neo-synalar® cream is indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. it has not been demonstrated that this steroid-antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment (see warnings section) . topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. this product should not be used in the external auditory canal if the eardrum is perforated.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 1 mg in 1 mg - capex® shampoo is a low to medium potency corticosteroid indicated for the treatment of seborrheic dermatitis of the scalp. this product has not been proven to be effective in other corticosteroid-responsive dermatoses. capex® shampoo is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Canada - English - Health Canada

medicis canada ltd. - fluocinolone acetonide; neomycin (neomycin sulfate); polymyxin b sulfate - solution - 0.25mg; 3.5mg; 10000unit - fluocinolone acetonide 0.25mg; neomycin (neomycin sulfate) 3.5mg; polymyxin b sulfate 10000unit - antibacterials

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 0.11 mg in 118.28 ml - fluocinolone acetonide 0.01% topical oil is indicated for the topical treatment of atopic dermatitis in adult patients. fluocinolone acetonide 0.01% topical oil is indicated for the topical treatment of moderate to severe atopic dermatitis in pediatric patients, 3 months and older for up to 4 weeks. safety and effectiveness in pediatric patients younger than 3 months of age have not been established. apply the least amount of fluocinolone acetonide 0.01% topical oil needed to cover the affected areas. as with other corticosteroids, fluocinolone acetonide 0.01% topical oil should be discontinued when control of disease is achieved. contact the physician if no improvement is seen within 2 weeks. fluocinolone acetonide 0.01% topical oil should not be applied to the diaper area; diapers or plastic pants may constitute occlusive use. fluocinolone acetonide 0.01% topical oil should not be used on the face, axillae, or groin unless directed by the physician.  application to intertriginous areas should be avoided due

United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 0.11 mg in 1 ml - fluocinolone acetonide topical oil, 0.01% is indicated for the topical treatment of atopic dermatitis in adult patients. fluocinolone acetonide topical oil, 0.01% is indicated for the topical treatment of moderate to severe atopic dermatitis in pediatric patients, 3 months and older for up to 4 weeks. safety and effectiveness in pediatric patients younger than 3 months of age have not been established. apply the least amount of fluocinolone acetonide topical oil, 0.01% needed to cover the affected areas. as with other corticosteroids, fluocinolone acetonide topical oil, 0.01% should be discontinued when control of disease is achieved. contact the physician if no improvement is seen within 2 weeks. fluocinolone acetonide topical oil, 0.01% should not be applied to the diaper area; diapers or plastic pants may constitute occlusive use. fluocinolone acetonide topical oil, 0.01% should not be used on the face, axillae, or groin unless directed by the physician. application to intertriginous areas should be avo